









Huseyin Engin is a Turkish doctor, medical oncologist, and professor. He provides consultations and treatment at Acıbadem Ataşehir Hospital in Istanbul.
His main focus is gastrointestinal oncology. This is one of the most complex areas in oncology, including the treatment of stomach cancer, colorectal cancer, pancreatic cancer, liver cancer, esophageal cancer, and biliary tract tumors. These diseases often require the sequential use of chemotherapy, surgery, and additional therapy, and sometimes immunotherapy and targeted treatment.
He received his education at one of the strongest universities in Turkey — Hacettepe University: medical degree (1994), subspecialty in internal medicine (1999), subspecialty in medical oncology (2003). From 2004 to 2021, he held academic positions at Zonguldak Bulent Ecevit University — from assistant professor to full professor. Since 2022, he has been working at Acıbadem Healthcare Group.
He has a number of publications on specific clinical issues:
For a patient with a tumor of the stomach, colon, pancreas, liver, or esophagus, this is a clear choice: an experienced academic oncologist focused specifically on these diseases, working in a major private clinic with a multidisciplinary approach.
Medical oncology.
Narrow focus — gastrointestinal oncology (stomach cancer, colorectal cancer, pancreatic cancer, liver cancer, esophageal cancer, and other digestive system tumors).
He also treats patients with breast cancer, lung cancer, and other solid tumors.
There are publications in PubMed / Google Scholar — articles on clinical oncology, including:
Main areas: gastrointestinal oncology, lung cancer, elderly patients in oncology, molecular markers.

Acıbadem Ataşehir is one of the flagship clinics of Acıbadem Healthcare Group. For a patient with a gastrointestinal tumor, the full treatment cycle is concentrated here: surgical oncology (including HPB surgery), medical oncology, radiation oncology, and endoscopic methods of diagnosis and treatment.
The clinic is equipped for modern treatment methods: chemotherapy, immunotherapy, targeted therapy, and molecular testing of tumors to select individual treatment regimens. Clinical trials of new drugs are also available.
